{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:10:45Z","timestamp":1761844245888},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.2478\/v10039-012-0047-1","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T16:22:21Z","timestamp":1366042941000},"page":"31-37","source":"Crossref","is-referenced-by-count":12,"title":["Endothelial dysfunction in Graves' disease"],"prefix":"10.1016","volume":"58","author":[{"given":"A","family":"Pop\u0142awska-Kita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Szelachowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Modzelewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Siewko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Dzi\u0119cio\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PA","family":"Klimiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"G\u00f3rska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6\u20137","key":"10.2478\/v10039-012-0047-1_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/08916930310001603037","article-title":"The contribution of immune regulatory and thyroid specific genes to the etiology of Graves' and Hashimoto's diseases","volume":"36","author":"Ban","year":"2003","journal-title":"Autoimmunity"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcla.20067","article-title":"Interleukin-1-beta gene, but not the interleukin-1 receptor antagonist gene, is associated with Graves' disease","volume":"19","author":"Chen","year":"2005","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.2478\/v10039-012-0047-1_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/105072501300042820","article-title":"Endothelial function in patients with hyperthyroidism before and after treatment with propanolol and thiamazole","volume":"11","author":"Burggraaf","year":"2001","journal-title":"Thyroid"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/hq0102.101770","article-title":"Pulse wave analysis- clinical evaluation of a non-invasive, widely applicable method for assessing en-dothelial function","volume":"22","author":"Wilkinson","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1507\/endocrj.52.421","article-title":"The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism","volume":"52","author":"Tamer","year":"2005","journal-title":"Endocr J"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000311519","article-title":"Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment","volume":"18","author":"Pedro","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"10","key":"10.2478\/v10039-012-0047-1_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1089\/jir.2011.0049","article-title":"Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity","volume":"31","author":"Ganesh","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.2478\/v10039-012-0047-1_bib9","first-page":"207","article-title":"The thyroid and autoimmunity","volume":"47","author":"Lichiardopol","year":"2009","journal-title":"Rom J Intern Med"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1507\/endocrj.K06-176","article-title":"Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients","volume":"54","author":"Akinci","year":"2007","journal-title":"Endocr J"},{"issue":"6","key":"10.2478\/v10039-012-0047-1_bib11","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/105072503322238764","article-title":"Thyrotropin stimulates production of procoagulant and vasodilative factors in human aortic endothelial cells","volume":"13","author":"Donnini","year":"2003","journal-title":"Thyroid"},{"issue":"2","key":"10.2478\/v10039-012-0047-1_bib12","first-page":"58","article-title":"Proinflammatory cytokines levels in hyperthyroidism","volume":"26","author":"Senturk","year":"2003","journal-title":"Clin Invest Med"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2002.01629.x","article-title":"Serum concentrations of tumor necrosis factor-alpha and soluble TNF- receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function","volume":"57","author":"Diez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.2478\/v10039-012-0047-1_bib14","first-page":"639","article-title":"Serum cytokines levels in Graves' disease","volume":"21","author":"Al-Humaidi","year":"2000","journal-title":"Saudi Med J"},{"issue":"6","key":"10.2478\/v10039-012-0047-1_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1530\/eje.0.1320668","article-title":"Serum levels of interleukin 6 and tumor necrosis factor- in hyperthyroid patients before and after propylthiouracil treatment","volume":"132","author":"Celik","year":"1995","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.2478\/v10039-012-0047-1_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1530\/eje.0.1430197","article-title":"Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking","volume":"143","author":"Salvi","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.2478\/v10039-012-0047-1_bib17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0006-291X(92)91234-H","article-title":"Soluble forms of E-selectin, ICAM-1, and VCAM-1 are present in the super-natants of cytokine-activated cultured endothelial cells","volume":"187","author":"Pigott","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.2478\/v10039-012-0047-1_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF03347455","article-title":"Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyreoidism","volume":"34","author":"De Ciuceis","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"10","key":"10.2478\/v10039-012-0047-1_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.numecd.2010.02.023","article-title":"Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: Relevance to vascular inflammation","volume":"21","author":"Jublanc","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2249.1992.tb06876.x","article-title":"Adhesion molecule expansion in Graves' thyroid glands; potential relevances of granule membrane protein (GMP-140) and intercellular adhesion molecule-i (ICAM-1) in the homing and antigen presentation pro-cesses","volume":"89","author":"Miyazaki","year":"1992","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.2478\/v10039-012-0047-1_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jcem-63-2-407","article-title":"Effect of thyroid hormones on plasma protein concentrations in man","volume":"63","author":"Graninger","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0030-1270067","article-title":"Thyroid Disorders and Hypercoagulability","volume":"37","author":"Erem","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"8","key":"10.2478\/v10039-012-0047-1_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1055\/s-2007-1000372","article-title":"Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review","volume":"33","author":"Mina","year":"2007","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1995.tb00899.x","article-title":"Primary haemostasis in thyroid disease","volume":"238","author":"Myrup","year":"1995","journal-title":"J Intern Med"},{"issue":"12","key":"10.2478\/v10039-012-0047-1_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1046\/j.1365-2362.1998.00381.x","article-title":"Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity","volume":"28","author":"Li","year":"1998","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.2478\/v10039-012-0047-1_bib26","first-page":"CR42","article-title":"Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism","volume":"14","author":"Coban","year":"2008","journal-title":"Med Sci Monit"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2002.01629.x","article-title":"Serum concentrations of tumor necrosis factor-alpha (TNF) and soluble TNF-receptor p55 in patients with hypothyroidism and hyperthyroidism before and after normalization of thyroid function","volume":"57","author":"Diez","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.2478\/v10039-012-0047-1_bib28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1507\/endocrj.K06-176","article-title":"Thrombin activatable fibrinolysis inhibitor antigen levels are inversely correlated with plasminogen activator inhibitor-1 antigen levels in hyperthyroid patients","volume":"54","author":"Akinci","year":"2007","journal-title":"Endocr J"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112614601681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T15:35:40Z","timestamp":1562945740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112614601681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1896112614601681"],"URL":"https:\/\/doi.org\/10.2478\/v10039-012-0047-1","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}